Latest news with #Yitzhak
Cision Canada
2 days ago
- Business
- Cision Canada
Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
Else Nutrition Welcomes 3 Major Federal Developments that Could Unlock Market Access & Open the Door to the First Major Breakthrough in Infant Formula in Decades VANCOUVER, BC, June 10, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the"Company"), a global leader in clean label, plant-based childhood nutrition, welcomes a recent trio of significant policy signals from the U.S. Government that could reshape the nation's infant formula landscape. These developments - spanning FDA regulatory reform, Congressional oversight, and executive action - reflect growing national momentum to modernize outdated regulations and expand consumer choice in baby formula. National Academy Report Supports Smarter Science, Aligns with Else's Regulatory Approach In a move that could have broad implications for new formula entrants, the FDA commissioned a National Academy of Sciences study to examine global regulatory standards for infant formula - particularly focusing on the outdated Protein Efficiency Ratio (PER) study, which had long served as a barrier for plant-based options like Else's. The newly released study recommends replacing the outdated PER test with modern, evidence-based alternatives that better reflect international norms and nutritional science. This marks a turning point for Else, whose regulatory strategy has been built around these same more progressive standards. "We are encouraged by the Academy's findings and look forward to these recommendations informing forthcoming FDA guidance," said Hamutal Yitzhak, CEO & Co-Founder, Else Nutrition. Congressional Pressure Grows for Modernized Plant-Based Infant Formula Pathway In parallel, Else Nutrition welcomes mounting attention to infant formula policy from the United States Congress. Earlier this year, top Republican Appropriators - a Members of a powerful Committee in Congress that maintains the "Power of the Purse" - sent a formal Congressional Oversight letter to the agency, urging the FDA to create a clear, modernized regulatory pathway for plant-based infant formula that matches the international standard. Congress' intent reflects a shared perspective that the National Academy study unveiled. This rare Congressional intervention emphasizes the urgency of reform and calls for U.S. policy to upgrade to international standards that already embrace plant-based options. It also signals the potential for future Congressional action to reinforce the need for change and hold the FDA accountable. "Congressional Appropriators are sending a strong signal that American parents deserve safe, vetted plant-based alternatives, and that companies like Else deserve a fair, science-aligned path to market, with regulatory guidance to match," added Ms. Yitzhak. Administration Launches 'Operation Stork Speed' to Cut Red Tape Furthering the support is the Administration's new initiative, Operation Stork Speed, aimed at accelerating access to infant formula by streamlining regulatory processes and clearing bureaucratic roadblocks. The program is expected to fast-track FDA reforms while ensuring safety and nutritional integrity. Else Nutrition looks forward to engaging directly with the Administration to help shape a smarter, more inclusive infant formula future. A New Era of Opportunity for Infant Nutrition Together, these three developments - scientific, legislative, and executive - signal a generational shift in how the U.S. regulates and supports infant nutrition. For Else Nutrition, they offer renewed confidence that the path forward is finally being cleared. This initiative is a direct complement to the Congressional attention and the National Academy study, and Else looks forward to collaborating with the Administration. "These reforms aren't just good for Else - they're good for every parent seeking cleaner, safer, baby formula options beyond dairy," said Ms. Yitzhak. "We continually get requests from so many families in real need of finding an alternative beyond dairy-based baby formula. We're proud to be at the forefront of this movement for change and are ready to serve American families with the trusted nutrition they deserve." Join the Movement: Demand Real Choice Else Nutrition is mobilizing parents, pediatric professionals, and policymakers to advocate for inclusive, evidence-based nutrition. With public support and FDA cooperation, the Company can launch clinical trials and bring its formula to American shelves. Here's how you can help drive the Formula for Change: Email your Member of Congress to urge FDA action on modern regulatory pathways. Sign the petition on to amplify the public voice. Learn more and take action today: DISCLAIMERS This grassroots lobbying effort is a statement of issue advocacy and does not require disclosure under the Lobbying Disclosure Act. This is not an electioneering statement, and this message has not been coordinated with any political parties or candidates. This message is paid for by Else Nutrition and is intended for only a "restricted class" of stockholders and administrators of the company. Whereas this is an instance of grassroots lobbying, Else Nutrition's engaged lobbying principals file disclosures required under the Lobbying Disclosure Act for direct lobbying services on behalf of the company. About Else Nutrition Holdings Inc. Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth. Awards and Recognition: "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category "Best Dairy Alternative" Award 2021 at World Plant-Based Expo Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon TSX Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking Statements This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. SOURCE Else Nutrition Holdings Inc.
The Guardian
27-02-2025
- Entertainment
- The Guardian
Hedwig and the Angry Inch review – the electrifying gender-bender we need right now
Cult shows never die; they're just reborn at a time of their own choosing. Stephen Trask and John Cameron Mitchell's defiantly genderqueer rock musical Hedwig and the Angry Inch returns at what feels like the perfect juncture, as the tides of history turn and trans people around the world are threatened with violence and erasure. A vivid and electrifying middle finger to intolerance and hate, Hedwig seems more necessary than ever. The role of Hedwig has long been coveted by musical theatre performers in a similar way that Shakespeare's Cleopatra is sought after by great actors – as a kind of zenith of the craft. The characters share certain qualities: they're quixotic and mercurial, tragicomic and self-mythologising. They can be incredibly cruel to the people around them; they love more passionately and completely than mere mortals. They're grand queens who command undivided attention. Australia had one notable Hedwig in 2006 with iOTA in the central role, and an aborted production which was due to star Hugh Sheridan in 2020. Now it's Seann Miley Moore's turn to don the glitter boots and Princess Leia wig in a production so attuned to their talent it often feels as if the show was written for them. Adelaide's aptly named Queens theatre heaves and sweats under the raw power of Moore's charisma, which they turn on the audience like a searchlight. Hedwig's story is a complicated one in many ways and yet its overall trajectory is incredibly simple, even primal. Forced into a botched gender reassignment surgery in order to escape a divided Berlin with her American lover, she is left with a mound of flesh instead of a vagina, the 'angry inch' of the title. Deserted by terrible men – including a wannabe teenage rock star, Tommy Gnosis, who steals her songs and becomes a success – she eventually marries a Croatian Jewish drag queen, Yitzhak (Adam Noviello), with whom she has a toxic co-dependency. She's only agreed to marry him if he swears never to dress in feminine clothing again. The musical takes place during one of Hedwig's gigs, with Gnosis performing in a stadium down the road – in a clever touch, Gnosis's songs of self-realisation can be heard intermittently through a door in the set. Hedwig's torment over this betrayal is curiously mirrored in her abuse of Yitzhak, her denial of his identity and suppression of his talent. Of course, resentment and jealousy will have their repercussions and by the end of the show Yitzhak's vocal virtuosity spectacularly emerges. Co-directors Shane Anthony and Dino Dimitriadis expertly finesse Hedwig's story, extracting huge reserves of humour and pathos, allowing for odd discursions while driving the narrative to its feverish finale. Jeremy Allen's set and Geoff Cobham's lighting are brilliantly evocative of the nightclub and the runway, and Nicol and Ford's costumes, with their denim-on-demin maximalism, are glamorous and subterranean. Enormous attention is paid in this production to aesthetics, an awareness of the power of possessions to articulate an inner life. The audience enters the outdoor foyer to discover the gorgeously detailed paraphernalia of Hedwig's world – slips hanging from clothes lines, booths lined with formica, a caravan full of exquisitely curated tat – in a reminder of what is acquired and must be sacrificed in the pursuit of self. Moore proved their star wattage in the recent Australian tour of Miss Saigon, queering the role of the Engineer to stunning effect. As Hedwig, they leap out of the starting gates with explosive energy and charm, milking the hilarious monologues for all they're worth while allowing flashes of pain and wretchedness. Moore's vocal range is impressive, their vibrato thumping through their lower register while a prog-rock hysteria animates the top notes. It's a masterful portrait of pugnacious vulnerability, the queer sensibility writ large. As the castigated sidekick who finds their voice, Noviello is a revelation. Surly, combative and desperately sad, Yitzhak is Hedwig's 'thing of darkness'. Noviello has a pure, golden tenor that is constantly arrested by Hedwig's self-regard, but when they emerge from captivity – triumphant in full drag glory– it's like a burst dam that washes over the hungry audience. Hedwig and the Angry Inch wears its influences on its sleeve as proudly as its heart. Trask's terrific songs draw heavily on Bowie and Lou Reed, those great pioneers of gender play, and oscillate between progressive and punk rock. There is a distinctly European sensibility animating the show, and yet this production manages to feel genuinely Australian, too. You can hear the echo of Reg Livermore's Betty Blokk Buster in Moore's performance, ballsy and confrontational, flirtatious and sincere. The world needs Hedwig right now, in this precise iteration. Trans defiance is never divorced from its vulnerability to outside aggression, and Moore and Noviello courageously stand proud against rising waves of hate. These extraordinary performers in their infinite variety, aided by a production of great consideration and vitality, define the fight for us. Now all we have to do is join the band. Hedwig and the Angry Inch plays at Adelaide festival until 15 March before touring to Melbourne and Sydney
